Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dopamine hydrochloride (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Dopamine adverse reaction |
Causative agent |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Dopamine measurement, urine |
Component |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Dopamine measurement, blood |
Component |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Dopamine/creatinine ratio measurement |
Component |
False |
Dopamine agent |
Inferred relationship |
Some |
|
24 hour urine free dopamine output measurement |
Component |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Urine free dopamine measurement |
Component |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Dopamine in Glucose 800micrograms/mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Dopamine measurement |
Component |
False |
Dopamine agent |
Inferred relationship |
Some |
|
dopaminhydrochlorid 400 mg/glucose infusionsvæske, opløsning, hætteglas a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
dopaminhydrochlorid 800 mg glucose infusionsvæske, opløsning, hætteglas a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Pramipexole (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Cabergoline (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Bromocriptine (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Levodopa (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Apomorphine (substance) |
Is a |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Dopamine preparation |
Is a |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Product containing dopamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Product containing quinagolide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
startpakke bestående af quinagolid 25 µg tablet og 50 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
quinagolid 75 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
Product containing ergoline derivative (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
dopaminhydrochlorid 80 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
dopaminhydrochlorid 80 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine agent |
Inferred relationship |
Some |
|